Magnani John L. 4
4 · GLYCOMIMETICS INC · Filed May 24, 2018
Insider Transaction Report
Form 4
Magnani John L.
DirectorVP of Research, CSO
Transactions
- Exercise/Conversion
Common Stock
2018-05-23$0.33/sh+1,491$492→ 100,793 total - Exercise/Conversion
Warrant to Purchase Common Stock (right to buy)
2018-05-23−596→ 0 totalExercise: $0.33From: 2009-01-16Exp: 2019-01-16→ Common Stock (596 underlying) - Exercise/Conversion
Warrant to Purchase Common Stock (right to buy)
2018-05-23−895→ 0 totalExercise: $0.33From: 2008-07-03Exp: 2018-07-03→ Common Stock (895 underlying)
Holdings
- 4,845(indirect: By GlycoTech Corporation)
Common Stock
Footnotes (1)
- [F1]These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.